Key result
Both brachial-ankle and carotid-femoral pulse wave velocity significantly predicted stroke and cardiovascular disease, though only cfPWV remained an independent predictor after multivariate adjustment.
Why the study?
Does brachial-ankle pulse wave velocity predict stroke and cardiovascular events compared to carotid-femoral pulse wave velocity in outpatients with essential hypertension?
Cohort (n=414)
Does brachial-ankle pulse wave velocity predict stroke and cardiovascular events compared to carotid-femoral pulse wave velocity in outpatients with essential hypertension?
Carotid-femoral PWV is a superior independent predictor of cardiovascular events compared to brachial-ankle PWV in hypertensive patients, though baPWV remains a useful screening tool for stroke risk.
Answers are grounded in this paper and cite their sources.
baPWV was associated with CV events in hypertension; leaves open whether it can substitute for cfPWV in practice.
Background: The measurement of carotid-femoral pulse wave velocity (cfPWV) is useful to predict storke and cardiovascular events in hypetensive patients as our previous cohort study Non-invasive Atheroslerotic evaluation in Hypertension (NOAH) sutdy. As the cfPWV is useful, but not easy to measure, it couldn’t be suitable for a practical use. Therefore we evaluated the usefulness of brachial-ankle PWV (baPWV) as a predicting factor of cardiovcascular events, which was measured by widely-used equipment formPWV/ABI (Colin Co. Ltd.), compared with cfPWV. Methods: We designed this study as a part of NOAH study. We selected 414 outpatients (male/female=242/172, mean age=61.2±12.0 y.o.) from anticipants of NOAH study (n=813 with essential hypertension), who were simultaneously undergone baPWV and cfPWV measured by AT-form, and their prognoses were followed by questionnaire or medical records. Mean follow-up period was 43.0±17.2 months. We set stroke and/or cardiovascular disease (CVD) as primary endpoint, and stroke, CVD, coronary artery disease (CAD) and mortality as secondary endpoint. During this follow-up period, 36 primary endpoints, 18 brain attacks, 19 heart diseases, 15 CADs and 10 deaths were recorded. Results: The baPWV were strongly correlated with cfPWV (regression analysis; r=0.580). Patients were equally divided into 4 groups by either baPWV or cfPWV and evaluated the prognostic impact by Kaplan-Meier analysis (Log-rank test). For primary endpoint, baPWV and cfPWV showed significant distributions (p=0.0268 and 0.0002, respectively). The baPWV did not show significant distribution for CVD, CAD, and mortality, but only for stroke (p=0.0015). On the other hand, cfPWV showed significant distribution for CVD, stroke (p=0.0094 and 0.0338, respectively), but neither for CAD nor mortality. By Cox proportional hazard model adjusted with confounders; age, sex, blood pressure, serum creatinine, diabetes and dyslipidemia, only cfPWV was adopted as predictive factor, but not baPWV. Conclusion: Although a further large scale multicenter trial is necessary, measurement of cfPWV may be better to predict cardiovascular event, but baPWV also can be a useful screening marker and predictor of future cardiovascular event.
No takes yet. Share an insight, caveat, or question.
Takagi et al. (2009) conducted a cohort in Essential hypertension (n=414). High brachial-ankle and carotid-femoral pulse wave velocity vs. Lower pulse wave velocity was evaluated on Stroke and/or cardiovascular disease (CVD) (p=0.0268 (baPWV) and 0.0002 (cfPWV)). Both brachial-ankle and carotid-femoral pulse wave velocity significantly predicted stroke and cardiovascular disease, though only cfPWV remained an independent predictor after multivariate adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: